Connor, Clark & Lunn Investment Management (CC&L)
KALA icon

Connor, Clark & Lunn Investment Management (CC&L)’s KALA BIO KALA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6
Closed -$127K – 1103
2020
Q1 		$127K Buy
+6
New +$95.9K ﹤0.01% 910

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s KALA Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of KALA BIO (KALA) in Q2 2020, closing a stake of 6 shares — an estimated $127K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in KALA in Q1 2020 and held it in 1 quarter. The position peaked at $127K in Q1 2020. 113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining KALA BIO position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 6 KALA BIO shares in Q2 2020, an estimated $127K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in KALA BIO in Q1 2020 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s KALA BIO position peaked at $127K in Q1 2020.
  • 113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.